What is Sunflower Pharmaceutical Group Co.,Ltd's (002737.SZ) StockRank?

MoatMap's StockRank for Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) is 89/100, with a Strong Buy signal. This is a composite score combining Quality (58), Value (58), and Momentum (62) factor ranks across MoatMap's 19,000+ stock universe.

Does Sunflower Pharmaceutical Group Co.,Ltd have an economic moat?

Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) has a Quality factor score of 58/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Sunflower Pharmaceutical Group Co.,Ltd a buy, hold, or sell?

MoatMap's current signal for Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) is Strong Buy, based on a StockRank of 89/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Sunflower Pharmaceutical Group Co.,Ltd in?

Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002737.SZ

STRONG BUYREMOVE

Sunflower Pharmaceutical Group Co.,Ltd · Healthcare · China · $1.1B · Avg Vol: $9M/d

StockRank

P/E (TTM)

—

ROE

-5.5%

D/E

0.0x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Sunflower Pharmaceutical is a Chinese domestic OTC drug manufacturer. It does not align with the CDMO Pricing Power Cycle or any other global macro themes, and is subject to domestic Chinese regulatory risks.

COMPANY DESCRIPTION

Sunflower Pharmaceutical Group Co., Ltd. manufactures and markets traditional Chinese medicines (TCM) and chemical drugs, with a primary focus on pediatric and adult OTC products. The company is a dominant market leader in China's pediatric OTC segment, leveraging its highly recognized "Little Sunflower" brand. It is characterized by its extensive nationwide OTC distribution network and strong brand equity in family healthcare.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	753M	842M	499M	343M	-23.1%
EPS	0.22	0.28	0.12	-0.07	-24.7%
Shares	584M	584M	584M	584M	0.0%
Debt	64M	4M	1M	17M	-35.7%
Equity	621M	704M	647M	567M	-3.0%
Op CF	292M	131M	-45M	85M	-33.7%
Inv CF	-95M	5M	375,012	-82M	—
Fin CF	-36M	-154M	-139M	-31M	—

PRICE (1M)-8.8%

SMA 50SMA 200

$1.83

RSI (14)

41.2

52W High

$2.54

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

-6.4%37.6

ROE

-5.5%39.2

GP/Assets

20.2%47.4

Op. Margin

18.9%80.9

FCF/Assets

10.4%88.4

Piotroski

—55.8

Int. Cover

-50.0x6.5

D/E Ratio

0.03x79.9

Current Ratio

3.33x57.2

Value

P/E (TTM)

—N/A

EV/EBITDA

-115.5x97.0

P/FCF

93.5x74.2

P/B

1.9x58.4

P/S

3.0x57.6

Div Yield

—N/A

Momentum

52W High %

72%60.4

RS 6M

-24%49.6

SMA 50/200

0.90x33.6

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—97.8

Q Growth

93%84.8

FUNDAMENTALS

Market Cap

$1.1B

P/E (Forward)

5.3x

Gross Margin

43.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002737.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002737.SZ	Sunflower Pharmaceutical Group Co.,Ltd(you)	$1.1B	89	STRONG BUY
002332.SZ	Zhejiang Xianju Pharmaceutical Co.,Ltd.	$1.2B	87	STRONG BUY
000989.SZ	Jiuzhitang Co., Ltd.	$1.0B	91	STRONG BUY
600993.SS	Mayinglong Pharmaceutical Group Co., Ltd.	$1.5B	88	STRONG BUY
002275.SZ	Guilin Sanjin Pharmaceutical Co., Ltd.	$1.2B	96	STRONG BUY
002349.SZ	Jinghua Pharmaceutical Group Co., Ltd.	$866M	85	STRONG BUY
000650.SZ	Renhe Pharmacy Co.,Ltd	$1.1B	97	STRONG BUY
600664.SS	Harbin Pharmaceutical Group Co., Ltd.	$1.3B	81	STRONG BUY
605507.SS	Guobang Pharma Ltd.	$1.8B	88	STRONG BUY
000915.SZ	Shandong Wit Dyne Health Co.,Ltd.	$946M	96	STRONG BUY

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) — Stock Score Summary

Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) has a MoatMap StockRank of 89/100 based on Quality (58/100), Value (58/100), and Momentum (62/100) factor scores. The current signal is STRONG BUY. Sunflower Pharmaceutical is a Chinese domestic OTC drug manufacturer. It does not align with the CDMO Pricing Power Cycle or any other global macro themes, and is subject to domestic Chinese regulatory risks.

Key Financial Metrics

Price	$1.83
Market Cap	$1.1B
P/E (Forward)	5.33
Price/Book	1.86
Return on Equity	-5.5%
Return on Invested Capital	-6.4%
Debt/Equity	2.70
Gross Margin	43.0%
Operating Margin	18.9%
Revenue Growth	27.2%
Free Cash Flow	$12M

Sunflower Pharmaceutical Group Co.,Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Sunflower Pharmaceutical Group Co.,Ltd’s (002737.SZ) StockRank?: MoatMap’s StockRank for Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) is 89/100, with a Strong Buy signal. It is a composite of Quality (58), Value (58), and Momentum (62) factor ranks across MoatMap’s 19,000+ stock universe.
Does Sunflower Pharmaceutical Group Co.,Ltd have an economic moat?: Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) has a Quality factor score of 58/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Sunflower Pharmaceutical Group Co.,Ltd a buy, hold, or sell?: MoatMap’s current signal for Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) is Strong Buy, based on a StockRank of 89/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Sunflower Pharmaceutical Group Co.,Ltd in?: Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).